-The Hindu Business Line Limited charging infrastructure, lack of interoperability services and inadequate access to affordable finance must be addressed Russia’s war on Ukraine has had a devastating impact on the global economy. It has triggered an unprecedented energy crisis as prices of commodities such as coal, natural gas and crude oil have skyrocketed. With oil above $100 a barrel, policymakers in the country are faced with two questions: How to keep...

On Janaushadhi Diwas this year (i.e., March 7th, 2022), Prime Minister Shri Narendra Modi stated that the poor and the middle-class benefited from the 'Jan Aushadhi Kendras' that were set up to provide generic drugs at affordable prices. He said that the poor and the middle class saved around Rs.13,000 crore through these stores during the COVID-19 pandemic. In the wake of COVID 19 crisis, the 'Bureau of Pharma PSUs of India'...

-Deccan Herald Improving Workforce Participation Unemployment at 7.9%! Many may wonder why so much is made of a ratio that has been hovering between 6% and 8% since 2017. In India, when 7% lose their jobs, it means more than 40 million are without work. In December 2021, the CMIE informed us that 53 million Indians were unemployed. Assuming that each individual supports at least four other dependents in the household, it...

-The Hindu Amidst the scattered experimentation now, the Centre must offer strategic policy guidance for inter-State coordination Only two years ago, in the wake of a nationwide lockdown, India was left shocked by the plight of migrant workers walking hundreds of kilometres, facing hunger, exhaustion and violence, to get to the safety of their home villages. The dire circumstances of the migrants tugged at our collective heartstrings. They became the focus of...

-TheWire.in * The Parliamentary standing committee on chemicals and fertilisers has produced a report highlighting gaps in the availability of COVID-19 drugs and devices during the pandemic. * The committee has asked the national government why PSUs didn’t receive licenses to make COVID drugs when private manufacturers did. * The MPs on the committee also spotlighted widespread irrational drug use in COVID-19 management, despite the existence of a standard treatment protocol. New Delhi: The...